Hydroxytacrine maleate

CAS No. 118909-22-1

Hydroxytacrine maleate( —— )

Catalog No. M33745 CAS No. 118909-22-1

Hydroxytacrine maleate (Velnacrine maleate) is a cholinesterase (cholinesterase) inhibitor that enhances memory in rodents and may be used in the study of Alzheimer's dementia of the Alzheimer type (SDAT).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 29 In Stock
50MG 45 In Stock
100MG 73 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Hydroxytacrine maleate
  • Note
    Research use only, not for human use.
  • Brief Description
    Hydroxytacrine maleate (Velnacrine maleate) is a cholinesterase (cholinesterase) inhibitor that enhances memory in rodents and may be used in the study of Alzheimer's dementia of the Alzheimer type (SDAT).
  • Description
    Velnacrine maleate (HP 029) is an orally active cholinesterase inhibitor that can be used for the research of Alzheimer's disease.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    AChE
  • Recptor
    AChE
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    118909-22-1
  • Formula Weight
    330.34
  • Molecular Formula
    C17H18N2O5
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 30 mg/mL (90.82 mM)
  • SMILES
    C(=C\C(O)=O)\C(O)=O.NC1=C2C(=NC=3C1=CC=CC3)CCCC2O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Murphy MF, et al. Evaluation of HP 029 (velnacrine maleate) in Alzheimer's disease. Ann N Y Acad Sci. 1991;640:253-62.?
molnova catalog
related products
  • SEW06622

    SEW06622 is a potent inhibitor of acetylcholinesterase (AChE) and beta-secretase-1 (BACE-1) and is a potential candidate for the treatment of Alzheimer's disease.

  • Dihydrowithaferin A

    Dihydrowithaferin A is a withanolide isolated from Withania somnifera with activity against acetylcholinesterase (AChE). Dihydrowithaferin A in the diet may prevent or decrease the growth of tumors.

  • Rovatirelin

    Rovatirelin (S-0373) is a newly synthesized thyrotropin-releasing hormone (TRH) analog that ameliorates cytosine arabinoside-induced motor dysfunction in a rat model of spinal cerebellar degeneration via acetylcholine and dopamine neurotransmission.